| First complete chloroplast genomics and comparative phylogenetic analysis of Commiphora gileadensis and C. foliacea: Myrrh producing trees A Khan, S Asaf, AL Khan, A Al-Harrasi, O Al-Sudairy, NM AbdulKareem, ... PloS one 14 (1), e0208511, 2019 | 45 | 2019 |
| A CTC-cluster-specific signature derived from OMICS analysis of patient-derived xenograft tumors predicts outcomes in basal-like breast cancer H Thangavel, CD Angelis, S Vasaikar, R Bhat, MK Jolly, C Nagi, ... Journal of clinical medicine 8 (11), 1772, 2019 | 37 | 2019 |
| A novel role of ADGRF1 (GPR110) in promoting cellular quiescence and chemoresistance in human epidermal growth factor receptor 2‐positive breast cancer NM Abdulkareem, R Bhat, L Qin, S Vasaikar, A Gopinathan, T Mitchell, ... The FASEB Journal 35 (7), e21719, 2021 | 18 | 2021 |
| Complete chloroplast genomes of medicinally important Teucrium species and comparative analyses with related species from Lamiaceae A Khan, S Asaf, AL Khan, A Khan, A Al-Harrasi, O Al-Sudairy, ... PeerJ 7, e7260, 2019 | 14 | 2019 |
| Spectroscopic and Molecular Methods to Differentiate Gender in Immature Date Palm (Phoenix dactylifera L.) AL Khan, A Al-Harrasi, M Numan, NM AbdulKareem, F Mabood, ... Plants 10 (3), 536, 2021 | 11 | 2021 |
| NPY1R exerts inhibitory action on estradiol-stimulated growth and predicts endocrine sensitivity and better survival in ER-positive breast cancer R Bhat, H Thangavel, NM Abdulkareem, S Vasaikar, C De Angelis, L Bae, ... Scientific Reports 12 (1), 1972, 2022 | 10 | 2022 |
| Screening of GPCR drugs for repurposing in breast cancer NM Abdulkareem, R Bhat, RT Powell, S Chikermane, S Yande, L Trinh, ... Frontiers in Pharmacology, 2022 | 6 | 2022 |
| Transcriptomics of tapping and healing process in frankincense tree during resin production AL Khan, S Asaf, M Numan, NM AbdulKareem, M Imran, JJM Riethoven, ... Genomics 113 (6), 4337-4351, 2021 | 3 | 2021 |
| ADGRG1 promotes tumorigenesis, invasion/migration, and cell-cell adhesion in triple-negative breast cancer cells R Bhat, NM Abdulkareem, H Yasser, H Thangavel, MV Trivedi Cancer Research 80 (16_Supplement), 5148-5148, 2020 | 3 | 2020 |
| Comparing the effects of various β-blockers on cardiovascular mortality in breast cancer patients M Tabassum, SG Chikermane, C Johnson, NM Abdulkareem, EM Wang, ... Cardio-Oncology 10 (1), 17, 2024 | | 2024 |
| Designing an immunofluorescence-based biomarker assay for detecting Rb and Phospho-Rb expression in HR+/HER2-breast cancer M Tabassum, A Ruiz, NM Abdulkareem, MF Rimawi, GE Miles, MV Trivedi Cancer Research 83 (7_Supplement), 2136-2136, 2023 | | 2023 |
| Evaluating the effects of Bcl2 inhibitor, venetoclax, on cellular growth and clustering in triple-negative breast cancer cells AJ Ruiz, N Park, N Abdulkareem, M Trivedi Cancer Research 83 (7_Supplement), 2477-2477, 2023 | | 2023 |
| Abstract P6-10-19: Screening of GPCR-targeting drugs for repositioning in breast cancer N Abdulkareem, R Bhat, R Powell, S Chikermane, S Yande, L Trinh, ... Cancer Research 83 (5_Supplement), P6-10-19-P6-10-19, 2023 | | 2023 |
| ADGRF1 promotes tumorigenesis via the activation of STAT3 pathway in HER2+ and triple‐negative breast cancers NM Abdulkareem, R Bhat, MV Trivedi The FASEB Journal 36, 2022 | | 2022 |
| Abstract P2-11-09: Comparing the effects of various beta blockers on cardiovascular-related mortality in breast cancer patients NM Abdulkareem, SG Chikermane, S Gopinathan, ML Johnson, ... Cancer Research 82 (4_Supplement), P2-11-09-P2-11-09, 2022 | | 2022 |
| The Pharmacology and Molecular Mechanisms of ADGRF1 (GPR110) in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer N Abdulkareem | | 2022 |
| Developing an immunofluorescence assay for detecting Rb and phospho-Rb on circulating tumor cells in breast cancer T Kumar, H Thangavel, NM Abdulkareem, R Bhat, MV Trivedi Cancer Research 81 (13_Supplement), 591-591, 2021 | | 2021 |
| Design, optimization, and validation of multiplex immunofluorescence assay for detecting biomarker expression on circulating tumor cells in breast cancer T Kumar, H Thangavel, R Bhat, NM Abdulkareem, LE Dobrolecki, ... Cancer Research 80 (16_Supplement), 5383-5383, 2020 | | 2020 |
| Abstract P3-06-07: ADGRF1 overexpression inhibits tumor growth in vivo by inducing cell cycle arrest in HER2+ breast cancer R Bhat, NM Abdulkareem, L Qin, C De Angelis, H Yasser, H Thangavel, ... Cancer Research 80 (4_Supplement), P3-06-07-P3-06-07, 2020 | | 2020 |
| ADGRF1 signaling pathways in Breast Cancer Noor Mazin AbdulKareem, Raksha Bhat, Lanfang Qin, Rachel Schiff, Meghana V ... FASEB 34 (S1), 2020 | | 2020 |
